FDA Drug recall D-0205-2024
Sertraline Tablets, USP 100 mg, 30 tablets per bottle, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for: Cipla USA, Inc.,…
- FDA Drug
- Class II
- ongoing
- Published 2024-01-03
On 2024-01-03 the FDA classified a Class II recall of Sertraline Tablets, USP 100 mg, 30 tablets per bottle, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for: Cipla USA, Inc.,… by Legacy Pharmaceutical Packaging, citing CGMP Deviations: Inadequate line clearance which may result in a potential comingling of product.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0205-2024 |
| Classification | Class II |
| Status | ongoing |
| Initiated | 2023-12-11 |
| Published | 2024-01-03 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Legacy Pharmaceutical Packaging |
| Distribution | AR, CA |
Product
Sertraline Tablets, USP 100 mg, 30 tablets per bottle, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, Packaged by: Legacy Pharmaceutical Packaging LLC., Earth City, MO 63045, NDC# 68645-523-54
Reason
CGMP Deviations: Inadequate line clearance which may result in a potential comingling of product.
Identifiers
| ndc | 68645-521-54 |
|---|---|
| ndc | 68645-522-54 |
| ndc | 68645-523-54 |
| code_info | Lot #: 222033, exp. date 08/31/2024 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0205-2024%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.